SCHEMBL30382887

SCHEMBL30382887

O=C(/C=C/c1cccc(O)c1)c1ccc(N2CCC(O)CC2)cc1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.74
▸ NPC1 O15118 3/20 0.74
▸ RAB9A P51151 3/20 0.74
▸ HDAC3 O15379 2/20 0.57
▸ HDAC4 P56524 2/20 0.57
▸ HDAC1 Q13547 2/20 0.57
▸ HDAC7 Q8WUI4 2/20 0.57
▸ HDAC2 Q92769 2/20 0.57
▸ HDAC10 Q969S8 2/20 0.57
▸ HDAC11 Q96DB2 2/20 0.57
▸ HDAC8 Q9BY41 2/20 0.57
▸ HDAC6 Q9UBN7 2/20 0.57
▸ HDAC9 Q9UKV0 2/20 0.57
▸ HDAC5 Q9UQL6 2/20 0.57
▸ MAOB P27338 3/20 0.57
▸ ALDH1A1 P00352 2/20 0.57
▸ L3MBTL1 Q9Y468 2/20 0.57
▸ KDR P35968 2/20 0.57
▸ MAOA P21397 1/20 0.57
▸ NPSR1 Q6W5P4 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25216238 1.00 MAPT (0.74) MAPTNPC1RAB9AHDAC3HDAC4
SCHEMBL30383968 1.00 MAPT (0.74) MAPTNPC1RAB9AHDAC3HDAC4
SCHEMBL25200446 1.00 MAPT (0.74) MAPTNPC1RAB9AHDAC3HDAC4
SCHEMBL25195512 0.87 HDAC3 (0.59) MAPTNPC1RAB9AHDAC3HDAC4
SCHEMBL25194993 0.87 MAPT (0.75) MAPTNPC1RAB9AHDAC3HDAC4
SCHEMBL31233292 0.87 CA1 (0.59) MAPTNPC1RAB9AHDAC3HDAC4
SCHEMBL25200405 0.87 HDAC3 (0.59) MAPTNPC1RAB9AHDAC3HDAC4
SCHEMBL25208894 0.87 CA1 (0.59) MAPTNPC1RAB9AHDAC3HDAC4
SCHEMBL25208497 0.87 MAPT (0.75) MAPTNPC1RAB9AHDAC3HDAC4
SCHEMBL25189333 0.87 CA1 (0.59) MAPTNPC1RAB9AHDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024233598-A1 COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS YewSavin, Inc. (US) 2024-11-14 — — WO disclosed
EP-4429763-A1 COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS Yewsavin, Inc. (US) 2024-09-18 — — EP disclosed
WO-2023086388-A1 COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS YewSavin, Inc. (US) 2023-05-19 — — WO disclosed
Send feedback